AQUASOL A Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aquasol A, and when can generic versions of Aquasol A launch?
Aquasol A is a drug marketed by Astrazeneca and Casper Pharma Llc and is included in two NDAs.
The generic ingredient in AQUASOL A is vitamin a palmitate. There are fifty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vitamin a palmitate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AQUASOL A?
- What are the global sales for AQUASOL A?
- What is Average Wholesale Price for AQUASOL A?
Summary for AQUASOL A
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 4 |
Drug Prices: | Drug price information for AQUASOL A |
What excipients (inactive ingredients) are in AQUASOL A? | AQUASOL A excipients list |
DailyMed Link: | AQUASOL A at DailyMed |
Recent Clinical Trials for AQUASOL A
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dr Meru S | N/A |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 1 |
NICHD Neonatal Research Network | Phase 1 |
US Patents and Regulatory Information for AQUASOL A
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca | AQUASOL A | vitamin a | CAPSULE;ORAL | 083080-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Astrazeneca | AQUASOL A | vitamin a | CAPSULE;ORAL | 083080-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Casper Pharma Llc | AQUASOL A | vitamin a palmitate | INJECTABLE;INJECTION | 006823-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |